You are here

US allows emergency use of first Covid-19 antibody drug

rk_lilly_101120.jpg
The Food and Drug Administration (FDA) granted emergency use authorisation (EUA) to Eli Lilly & Co's bamlanivimab based on trial data showing that a one-time infusion of the treatment reduced the need for hospitalisation or emergency room visits in high-risk Covid-19 patients.

[BENGALURU] US regulators on Monday authorised emergency use of the first experimental antibody drug for Covid-19 in patients who are not hospitalised but are at risk of serious illness because of their age or other conditions.

The Food and Drug Administration (FDA) granted emergency use...

BT is now on Telegram!

For daily updates on weekdays and specially selected content for the weekend. Subscribe to t.me/BizTimes